ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

DRUG Bright Minds Biosciences Inc

1.2624
0.1599 (14.50%)
May 28 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
CAD ($)CAD ($)CAD ($)
Total Revenue 00000000
Operating Income -4.12M-2.65M-2.82M-2.09M-1.77M-2.23M-2.24M-1.45M
Pre Tax Income -4.49M-2.66M-2.96M-2.34M-2.05M-1.46M-1.53M-1.68M
Net Income -4.49M-2.66M-2.96M-2.34M-2.05M-1.46M-1.53M-1.68M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -4.12M-2.65M-2.82M-2.09M-1.77M-2.23M-2.24M-1.45M
EBITDA -4.12M-2.65M-2.82M-2.09M-1.74M-2.27M-2.17M-1.43M
Year End September 29 2023 202120222023
CAD ($)CAD ($)CAD ($)
Total Revenue 000
Operating Income -7.68M-13.31M-6.56M
Pre Tax Income -8.65M-14.97M-7.37M
Net Income -8.65M-14.97M-7.37M
Preferred Dividends 000
Basic Earnings Per Share (EPS) -0.731-0.851-1.954
EBIT -7.68M-13.31M-6.56M
EBITDA -7.68M-13.31M-6.48M